Morphic Medical (formerly GI Dynamics Inc.) is the developer of RESET® (fka EndoBarrier), an endoscopically delivered device therapy that offers a non-surgical, alternative treatment for the treatment of type 2 diabetes and obesity. RESET is approved for sale in the EU and UK and limited to Investigational Use in the U.S. Founded in 2003, Morphic Medical is headquartered in Boston, Massachusetts.
| Website | https://morphicmedical.com |
| Employees | 56 (32 on RocketReach) |
| Founded | 2003 |
| Address | 355 Congress St., Boston, Massachusetts 02210, US |
| Phone | +1 781-357-3300 |
| Industry | Medical Devices |
| Keywords | Type 2 Diabetes Treatment, Obesity Treatment, Non Surgical Weight Loss, Diabetes Management, Metabolic Health, Gastrointestinal Health, Minimally Invasive, Diabetes Technology, Obesity Management, Digestive Health, Health Technology, Chronic Disease Management |
| Competitors | Medtronic, Boston Scientific, Johnson & Johnson, Cook Medical, Stryker, Abbott, Baxter International Inc., Terumo, Zimmer Biomet, Cardinal Health +40 more (view full list) |
Looking for a particular Morphic Medical employee's phone or email?
Mike G. is the President and CEO of Morphic Medical.
32 people are employed at Morphic Medical.
Morphic Medical is based in Boston, Massachusetts.